General Wellness vs Medical Device: How FDA Decides at Import

The line between general wellness vs medical device is not drawn by the hardware. Two identical massage guns can arrive in the same container, one marketed to relieve post-workout tightness and the other to treat back pain, and FDA will treat only the second as a regulated medical device. That difference decides whether the shipment needs a registered foreign manufacturer, a device listing and, for many product types, a premarket clearance number before it can clear.

FDA revised its guidance General Wellness: Policy for Low Risk Devices on January 6, 2026, replacing the 2019 version. The revision widens the wellness category for non-invasive sensors that report physiological values, and it keeps several product types firmly on the device side. This guide sets out the test FDA applies, the claims that flip a product, where common fitness and beauty-tech imports land, and what changes in the ACE entry once a product is treated as a device.

The Test FDA Applies Under the Revised Wellness Guidance

The statutory anchor is section 520(o)(1)(B) of the Federal Food, Drug, and Cosmetic Act, which removes certain software functions intended for a healthy lifestyle, and unrelated to the diagnosis, cure, mitigation, prevention or treatment of a disease or condition, from the device definition. For hardware, the general wellness guidance works as a compliance policy: FDA states it does not intend to examine low risk general wellness products to determine whether they are devices or whether they meet device requirements.

The guidance works as a two-part screen. First, the intended use has to be a general wellness use: maintaining or encouraging a healthy lifestyle, without reference to a specific disease or condition. Second, the product has to be low risk. A product that fails either part is assessed as a device under the normal classification rules, and the wellness policy offers no cover.

The January 6, 2026 revision changed the first part for wearables. Non-invasive sensing that outputs vital-sign values can now sit inside the wellness policy, provided the output is not diagnostic and does not prompt the user toward clinical action. A sleep band that reports overnight pulse trends for fitness purposes can fit that description. The same band marketed to flag an irregular rhythm for a doctor’s attention does not.

The revision also names exclusions. Products intended to measure physiologic values for medical or clinical purposes, such as blood pressure monitors, fingerstick glucose meters, continuous glucose monitors and ECG recording and analysis devices, are outside the wellness policy. A non-invasive wearable that estimates blood pressure or glucose for fitness use can still qualify, but only if its values are validated and nothing in its labeling or interface points to a disease, a clinical threshold or clinical action. On the risk side, products that use lasers, emit radiation or apply neurostimulation are not treated as low risk, so a wellness claim does not take them out of device regulation.

Claims That Turn a Wellness Product Into a Device

FDA determines intended use from the objective evidence of how the product is sold. For an importer, that evidence is the whole commercial footprint: the carton and insert, the Amazon or retailer listing, the brand website, paid ads and influencer copy. A clean retail box does not help if the marketplace listing for the same SKU promises pain relief.

The shift usually happens through a single verb. Words such as treat, relieve, cure, prevent, diagnose, heal or reduce symptoms, attached to a named disease or condition, move a product out of wellness and into device territory. Words such as relax, recover, energize, tone or track, attached to general fitness or lifestyle goals, keep it inside the policy, subject to the risk screen.

Where claims hide in an import program

Large importers rarely write every claim themselves. Foreign manufacturers print English-language inserts, marketplace sellers edit product titles, and affiliate content repeats whatever converts best. Because FDA reviews the product as marketed, a compliance review has to cover the listing and advertising that will run in the US, not only the physical label that crosses the border.

Where Massage Guns, TENS Units, LED Masks and Wearables Land

Once a product falls outside the wellness policy, FDA’s device classification regulations decide what it needs. The classifications below are the ones most often triggered by fitness and beauty-tech imports. Class I carries general controls; Class II adds special controls and, unless exempt, a 510(k) clearance before marketing.

The table is a starting point, not a ruling. Where a product’s classification is genuinely unclear, the manufacturer or US brand owner can ask FDA for a formal answer through a 513(g) request for information. Posture correctors are a common example: depending on design and claims they can be a wellness product or a Class I orthosis, so confirm the classification product by product before booking.

Why a massage gun and a TENS unit are treated differently

A percussion massager with a relaxation claim can sit inside the wellness policy, and with a claim to relieve minor muscle aches and pains it falls under 890.5660, a Class I type that is exempt from premarket notification subject to the limitations in 21 CFR 890.9. Claims that go beyond minor aches, such as treating a chronic condition, can cancel that exemption. A TENS or EMS unit applies electrical stimulation, which the guidance treats as outside the low-risk category, so it is regulated as a Class II device under 882.5890 or 890.5850 whatever the marketing says. FDA also maintains Import Alert 89-01 for powered muscle stimulators and iontophoresis devices, which allows detention without physical examination of listed firms’ products.

LED masks and light panels

Over-the-counter LED devices that claim to reduce wrinkles sit under 878.4810 with product code OHS and need 510(k) clearance. Light-based products also raise a separate question: whether they fall under an FDA radiation performance standard. Most LED masks and LED bulbs are not covered by one, which means no Form FDA 2877 declaration, but lasers are, and a laser-based beauty device has to meet both the device and the radiation data requirements at entry.

What Changes in the ACE Entry When the Product Is a Device

A wellness product that is not a device is not transmitted to FDA as a device. Once the product is a device, the broker files the FDA message set in ACE under the device program, with processing codes that distinguish non-electronic devices from radiation-emitting ones, and the entry has to carry specific Affirmation of Compliance codes that FDA’s systems match against its registration and listing databases.

For a finished device from a foreign manufacturer, FDA’s March 10, 2026 ACE guidance identifies DEV (foreign manufacturer registration number), DFE (foreign exporter registration number) and LST (device listing number) as the core codes, plus PM# carrying the 510(k) or other premarket number where the device has been cleared. The premarket number should match the one on the listing record. Declaring a code FDA does not recognize results in an entry rejection.

Device status does not change the duty side of the entry. HTS classification is a separate decision from the FDA product code, and device lines carry no blanket carve-out from additional duties: USTR’s Section 301 forced-labor tariffs include no general exemption for medical devices, so landed cost has to be modeled on both tracks.

• Foreign manufacturer registered and device listed under 21 CFR 807.40. No device may be imported unless it is listed and made at a registered foreign establishment.
• Premarket number available where the classification requires 510(k), and consistent with the listing.
• US importer registration in place where the importer acts as FDA initial importer under 21 CFR 807.20(a)(5).
• Correct FDA product code on the line, which identifies the device type to FDA’s screening system.
• Device Identifier data ready where required, since Import Alert 99-49 covers devices without a UDI or a matching GUDID record.

Import Consequences of Getting the Classification Wrong

The costly error is filing a device as a non-device consumer product, or importing a device from a foreign firm that never registered or listed because it assumed the product was wellness. FDA screens entries against its databases and its import alerts, and the gaps are visible. Import Alert 99-34 covers drugs and devices from firms without valid registration or listing. Import Alert 89-08 covers devices lacking a required 510(k) or PMA. Import Alert 80-06 covers devices with false or misleading labeling. Each allows detention without physical examination of the products it lists.

When FDA detains a device shipment, the importer gets a limited window to respond, and a refused shipment has to be exported or destroyed under supervision within 90 days of the refusal notice. Goods released to the importer under bond before FDA’s decision can be the subject of a redelivery demand, which is why the right customs bond and clean entry data matter on device lines. The hold also stalls every unit behind it, which for a seasonal launch can mean missing the selling window entirely.

Misclassification also reaches beyond the border. A US brand that sets the specifications for a private-label device made by a contract manufacturer is a specification developer under 21 CFR 807.20(a)(1): it registers, lists, pays the annual establishment fee ($13,785 for FY2027) and falls under the Quality Management System Regulation. The QMSR, which incorporates ISO 13485 by reference, has applied since February 2, 2026. An importer that relabels, repacks or assembles kits of devices also becomes subject to it.

A Pre-Shipment Claim Review for Import Teams

The review that prevents most holds takes place before the purchase order is finalized, not after the vessel sails. It compares the product and every channel of its marketing against the wellness policy and the device classifications, then fixes the entry data or the claims before either reaches FDA.

A practical sequence for compliance and trade teams runs in five steps:

Where a broker fits

A licensed broker cannot make a product a wellness product, but it can make sure the entry matches the regulatory position the importer has taken and that the data FDA screens is complete. CargoTrans handles device and non-device entries through its customs brokerage team and supports claim and classification reviews as part of trade compliance management. For products that are also restricted or prohibited on other grounds, see our guide to prohibited and restricted imports.

• Collect every claim for the SKU: packaging, insert, marketplace listing, website and ad copy, in the versions that will run in the US.
• Screen the product type first. Invasive or implanted products, lasers, radiation exposure risks and neurostimulation stay on the device side regardless of claims. Blood pressure, glucose and ECG functions stay on the device side unless the product is non-invasive, intended solely for wellness use and shows validated values.
• Test the claims. Any disease or condition named alongside treat, relieve or diagnose points to a device.
• If it is a device, confirm the classification regulation, the premarket path, the foreign manufacturer’s registration and listing, and the premarket number before booking.
• Decide the entry profile with your broker: device program data and Affirmation of Compliance codes, or a non-device consumer product entry supported by a documented wellness assessment.

Frequently Asked Questions